Literature DB >> 9323515

Recurrent external ophthalmoparesis during hormonal therapy after thyroid ablation. Case report.

F Ferracci1, F Conte, B Marini, G Fassetta.   

Abstract

We here report the case of a patient who had undergone total thyroid ablation for Graves' disease. After the beginning of oral therapy with 1-thyroxine, she developed a left external ophthalmoparesis that remitted with the discontinuation of the drug and recurred whenever the replacement therapy (1-thyroxine or tri-iodothyronine) was reintroduced.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9323515     DOI: 10.1007/BF02080466

Source DB:  PubMed          Journal:  Ital J Neurol Sci        ISSN: 0392-0461


  10 in total

1.  Ocular changes in Graves' disease. A long-term follow-up study.

Authors:  I B HALES; F F RUNDLE
Journal:  Q J Med       Date:  1960-01

2.  Minimal thyroid ophthalmopathy.

Authors:  R H Spector; J A Carlisle
Journal:  Neurology       Date:  1987-11       Impact factor: 9.910

Review 3.  Endocrine ophthalmopathy: current ideas concerning etiology, pathogenesis, and treatment.

Authors:  D H Jacobson; C A Gorman
Journal:  Endocr Rev       Date:  1984       Impact factor: 19.871

Review 4.  Immunology of autoimmune thyroid diseases.

Authors:  C R Strakosch; B E Wenzel; V V Row; R Volpé
Journal:  N Engl J Med       Date:  1982-12-09       Impact factor: 91.245

5.  CT of the orbit: current status with high resolution computed tomography.

Authors:  G Wilms; J Smits; A L Baert
Journal:  Neuroradiology       Date:  1983       Impact factor: 2.804

6.  Beneficial effects of corticosteroids on ocular myasthenia gravis.

Authors:  M J Kupersmith; M Moster; S Bhuiyan; F Warren; H Weinberg
Journal:  Arch Neurol       Date:  1996-08

7.  Ophthalmopathic immunoglobulin in patients with Graves' ophthalmopathy.

Authors:  S Atkinson; M Holcombe; P Kendall-Taylor
Journal:  Lancet       Date:  1984-08-18       Impact factor: 79.321

8.  Immunohistochemical and ultrastructural studies on the exenterated orbital tissues of a patient with Graves' disease.

Authors:  T J Hufnagel; W F Hickey; W H Cobbs; F A Jakobiec; T Iwamoto; R C Eagle
Journal:  Ophthalmology       Date:  1984-11       Impact factor: 12.079

9.  Correlation of CT scanning and pathologic features of ophthalmic Graves' disease.

Authors:  S L Trokel; F A Jakobiec
Journal:  Ophthalmology       Date:  1981-06       Impact factor: 12.079

10.  Ultrasound in early thyroid orbitopathy.

Authors:  H J Shammas; D S Minckler; C Ogden
Journal:  Arch Ophthalmol       Date:  1980-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.